BioCentury
ARTICLE | Company News

Agencourt, Duke University deal

April 1, 2002 8:00 AM UTC

Agencourt will use its Solid Phase Reversible Immobilization (SPRI) technology to aid university researchers in sequencing genes of cancer cells at various stages of growth. The company also will use ...